Sentences with phrase «median age of patients»

The median age of patients was similar between the two groups, at 67 in the docetaxel group and 66 in the erlotinib group.

The median age of the patients included was 50 years.

The median age of the patients is 61 and all are heavily pretreated — the median number of prior therapies was 6.3.

Not exact matches

The median age was 66 and the majority of patients (88 percent) were treated for primary lung cancer.

The median patient age was 59 years (range 28 - 88), and 69 percent of patients were female.

The median participant age was 67, two - thirds of patients (67 percent) had stage T1 disease, and 89 percent fell in the GS 7 / PSA < 10 group.

The patients included six children and two adults, with a median age of 21 years.

921 patients with an average (median) age of 70 to 71 years participated in this study worldwide.

Patients for whom data were collected were mostly of older age (median 62 years), male (65.7 %), and had healthcare acquisition of infection (55.7 %).

Patient median age was 63 and all received treatment at Ohio State, Massachusetts General Hospital, MD Anderson, University of California — San Diego or University of Chicago.

A total of 409 patients (median age, 66 years) were included in the study, with a median time to study drug administration of 3.5 hours after diagnosis of shock.

The trial included 11 male and eight female patients, with a median age of 57.

It included 790 patients (median age of 63 years) who were enrolled and randomized from July 2006 to November 2012 to receive either ADT plus docetaxel every three weeks for six cycles or ADT alone.

With a median follow up of 22 months, the 2 - year overall survival probability was 60.7 % in patients aged 65 years or under and 55.6 % in patients aged over 65 years (P = 0.40).

Patients were well matched between the groups, with a median age of 60 years, primarily ECOG 0 performance status, and mostly grade 2/3 serous histology.

Of the 61 patients (median age 68 years), 38 received AZA and 23 received LDAC; 59 patients were evaluable for response.

Patients had a median age at surgery of 60 years and were evenly divided between male and female.

The median time to response was 1.8 months, and responses occurred regardless of tumor type, patient age, or specific TRK fusion characteristics.

A total of 50 patients (22 females, 28 males; median age of 58 years, range of 20 to 80) with brain tumors compromising the primary motor cortex and the cortico - spinal tract underwent pre-operative MRI and navigated TMS mapping.

The median age of the participants was 62 years (range 20 to 93), and 75 % of the patients were male as expected from the demographics of BC.

Baseline characteristics of the 87 patients were as follows: mean age 38.6 (SD 11.0) years; 69 men; 64 single; 24 lived alone, 17 lived with a partner, 31 lived with parents, and the remainder with others; 61 left school at 16 years; 76 were unemployed, five were in paid employment, six were in voluntary employment or similar, two had never worked; 64 were unskilled and 21 were skilled or professional; 78 had a diagnosis of schizophrenia, eight had schizoaffective psychosis, and two had delusional disorder; the median (range) duration of illness was 11 (1 - 42) years; median (range) number of admissions to hospital was 3 (0 - 20); 10 had a forensic psychiatric history; and 12 had a history of substance abuse.